The 'Goldman Fund' in memory of John Goldman

The iCMLf has established a special fund in honour of Professor John Goldman for people wanting to give a donation to the foundation in his memory. John Goldman was one of the co-founders and a visionary of the International CML Foundation. His legacy will live on through the direction set by his leadership as chairman and it is in his honour we continue to improve the lives of people living with CML worldwide through various programs.

Supporting young physicians dedicated to CML from the emerging regions

The ‘Goldman Fund’ will be used specifically for the training of young CML clinicians and scientists from the emerging regions. This was something that John was passionate about.

The Goldman Fund supports young physicians to attend and present their work at the annual John Goldman Conference on CML. Speakers at this premier CML meeting present the newest and often unpublished data that relate to the biology of CML and aspects of CML treatment. Having the opportunity to attend is of great benefit to physicians and scientists in the field of CML. Using the Goldman fund to support people from the emerging regions to this meeting gives them access to the latest advances and ideas in the management of CML along with opportunities to build lasting, constructive networks with colleagues from around the world.

In 2015 two physicians from Nigeria and Ukraine came to the meeting in Estoril and presented their work to the CML community. It was also a great opportunity for them to listen to the scientific sessions on the biology and management of CML and to get in touch with key opinion leaders in the field of CML.

Dr Uzma Zaidi
(Karachi, Pakistan)

Uzma Zaidi

‘I thank iCMLf for providing me the opportunity to participate in the 18th John Goldman Conference. I got a chance to listen to international experts, to see what approaches they are following and how they are managing their patients. This meeting has greatly enhanced my knowledge on CML and given me so many new ideas to better help my patients in home town, both from the diagnostic and the management point of view’.
(Dr Zaidi, Pakistan)

Uzma Zaidi was supported by the iCMLf Goldman Fund to attend the John Goldman Conference on CML in Houston in 2016. She also undertook a 4-week clinical preceptorship at the MD Anderson Cancer Center in Houston directly after her attendance at the meeting.

‘The main issue in Pakistan is to get access to regular monitoring for my patients.
I am hoping to learn some diagnostic techniques during the preceptorship and to improve my skills and knowledge in terms of diagnosis and biology of CML. This will help me to find solutions for my patients’.
(Dr Zaidi in advance of her preceptorship)

Professor of International Medicine

Peking University People’s Hospital

Peking University Institute of Hematology

China

Medical education

1984-1990: M.D. Peking University Health Science Center

Clinical history

2017 - present: Chief Physician and Professor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
2010 - 2017: Chief Physician and Associate Professor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
2004 - 2010: Associate Chief Physician of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
1996 - 2004: Attending Doctor of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology
1990 - 1996: Resident Physician of Internal Medicine, Peking University People's Hospital, Peking University Institute of Hematology

Research interests

Clinical research of CML, MPN, AML, ALL, and CLL

The iCMLf Corporate sponsors

We are incredibly grateful for the support of the following organisations.
The work of the iCMLf is life changing for the people and communities reached. Thank you for supporting our mission to improve outcomes for CML patients around the world.

What is the iCMLf?

The iCMLf is a Foundation established by a group of hematologists with a strong interest in CML.  Our mission is to improve the outcomes for patients with CML globally. We are currently registered as a charitable foundation in England and Wales but our charter is global.

What are our aims and priorities?

The aims of the International CML Foundation (iCMLf) are to foster and coordinate global clinical and research collaborations and to improve clinical practice and disease monitoring in CML. There are numerous activities that could come within this broad charter but the initial focus is to meet the needs in CML that are not already being met by other groups, particularly those needs that are best met by a global organization.

What are our guiding principles?

A focus on chronic myeloid leukemia and related disorders
A truly independent not-for-profit foundation
Collaboration with, but independence from, the pharmaceutical industry
A global foundation with broad representation from all geographic regions
Priorities and policies determined by hematologists and scientists involved  in CML research and patient care
Close consultation and cooperation with CML patient groups
Active collaborations with key national and regional leukemia groups

How is the iCMLf governed and financed?

The iCMLf has

The iCMLf was co-sponsor of the International Meeting on CML with the European School of Hematology held in Bordeaux, September 11-13 2009, and will provide scientific leadership for future annual meetings (eg in Washington DC in September 2010)